Participant ’s Diagnosis Halts Gene Therapy Clinical Trial
The FDA pauses the research program on a lentivirus-based treatment for a rare neurological condition after a patient developed a bone marrow disorder that could presage leukemia.
Source: The Scientist - Category: Science Tags: News & Opinion Source Type: news
More News: Brain | Clinical Trials | Gene Therapy | Genetics | Leukemia | Neurology | Neuroscience | Science